AIPING PHARM INC
GenericsAIPING PHARM INC is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease.
AIPING PHARM INC's Key Drugs
AIPING PHARM INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
AIPING PHARM INC's Recent FDA Approvals
New NDA/BLA approvals for AIPING PHARM INC over the last two years — novel drugs only, excluding generics and label supplements.
AIPING PHARM INC's Therapeutic Areas
AIPING PHARM INC's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Neurology, across 0 biologic and 2 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AIPING PHARM INC's Top Competitors
AIPING PHARM INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, GE HEALTHCARE, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
AIPING PHARM INC Pipeline Snapshot
Active clinical trials for AIPING PHARM INC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1972-07-13
- Latest
- 2026-06-15
- Applications
- 53